Healthcare Services

Metagenomics In Healthcare Market Outlook Highlighting Growth Drivers And Market Evolution

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Metagenomics In Healthcare Market From 2026 To 2030?

The metagenomics in healthcare market has observed rapid expansion in recent years. Its value is expected to rise from $2.44 billion in 2025 to $2.87 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.8%. The growth during previous periods can be ascribed to advancements in sequencing technologies, a higher incidence of infectious diseases, the broadening of microbiome research initiatives, an increasing demand for culture-independent diagnostics, and the availability of clinical-grade sequencing workflows.

The metagenomics in healthcare market is projected to experience substantial expansion in the coming years. By 2030, this market is forecasted to reach $5.46 billion, exhibiting a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this growth during the forecast period include the escalating adoption of precision diagnostics for infectious diseases, increased investments in microbiome-based therapies, the broadening scope of genomic epidemiology programs, greater integration of AI in analyzing microbes, and a heightened emphasis on individualized treatment approaches. Key trends shaping the forecast period involve a surge in the clinical application of metagenomic diagnostics, an expanding utilization of microbiome-driven disease profiling, enhanced incorporation of ngs in managing infections, the broadening of personalized microbial therapeutics research, and a sharpened focus on swiftly identifying pathogens.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp

What Significant Factors Are Influencing The Metagenomics In Healthcare Market Expansion?

The escalating incidence of infectious diseases is anticipated to stimulate the growth of the metagenomics in healthcare market moving forward. Infectious diseases are defined as ailments stemming from detrimental microorganisms such as bacteria, viruses, fungi, or parasites, which possess the capability to spread directly or indirectly among individuals. This increasing prevalence of infectious diseases is attributed to heightened travel, which enables the swift dissemination of pathogens across geographical boundaries. Metagenomics in healthcare plays a vital role in combating infectious diseases by facilitating the rapid and precise identification of pathogens, making it essential for managing infectious outbreaks. It further diminishes diagnostic ambiguity by analyzing complex microbial communities, thereby enhancing patient outcomes and guiding targeted therapeutic approaches. For instance, in February 2024, data from the UK Health Security Agency, a UK-based government agency, indicated that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England climbed to 4,850 in 2023, representing an increase of 10.7% from the 4,380 cases recorded in 2022. Consequently, the rising occurrence of infectious diseases is a key driver for the expansion of the metagenomics in healthcare market.

How Is The Metagenomics In Healthcare Market Categorized Across Its Segment Groups?

The metagenomics in healthcare market covered in this report is segmented –

1) By Types: Sample Extraction Kits, Metagenomics Kits

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray

3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing

4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits

2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

What Trends Are Affecting The Direction Of The Metagenomics In Healthcare Market?

Leading companies in the metagenomics in healthcare market are concentrating on creating innovative solutions, such as microbial community profiling, to improve disease diagnostics, facilitate personalized therapies, and further precision medicine. Microbial community profiling entails the thorough analysis and characterization of diverse microbial populations within a specific environment or sample, utilizing sequencing and bioinformatics tools to ascertain their composition, variety, and functional roles. For example, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, launched a Human Microbiome Metagenomics Sequencing Package aimed at advancing microbial research and healthcare applications. This package offers an automated, complete workflow for microbial community profiling, allowing for efficient analysis of human microbiome diversity, function, and disease associations through validated high-throughput platforms. It effectively minimizes manual effort, enhances consistency, and lowers expenses, thereby making large-scale and clinical microbiome research more accessible. Researchers benefit from swift and accurate microbial identification, alongside adaptable throughput, which supports biomarker discovery and progresses translational health research.

Which Firms Are Influencing Competition In The Metagenomics In Healthcare Market?

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc.

Get The Full Metagenomics In Healthcare Market Report:

https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

Where Is The Metagenomics In Healthcare Market Most Concentrated Geographically?

North America was the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Metagenomics In Healthcare Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

Browse Through More Reports Similar to the Global Metagenomics In Healthcare Market 2026, By The Business Research Company

Metagenomic Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Metabolomics Market Report

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Genomics In Cancer Care Market Report

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795